Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)
China · Delayed Price · Currency is CNY 16.61
+0.09 (0.54%)
Jun 9, 2026, 3:04 PM CST
SHE:000623 Market Cap
SHE:000623 has a market cap or net worth of 19.47 billion as of June 9, 2026. Its market cap has increased by 2.03% in one year.
Market Cap
19.47B
Enterprise Value
19.04B
Revenue
2.23B
Ranking
n/a
PE Ratio
7.10
Stock Price
16.61
Market Cap Chart
Since April 11, 2006, SHE:000623's market cap has increased from 2.63B to 19.47B, an increase of 641.56%. That is a compound annual growth rate of 10.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 19.37B | -15.41% |
| Dec 31, 2025 | 22.90B | 10.86% |
| Dec 31, 2024 | 20.65B | 20.79% |
| Dec 29, 2023 | 17.10B | 0.46% |
| Dec 30, 2022 | 17.02B | -19.09% |
| Dec 31, 2021 | 21.03B | 10.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tasly Pharmaceutical Group | 20.90B |
| Betta Pharmaceuticals | 20.58B |
| Kangmei Pharmaceutical | 20.05B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 19.71B |
| Chengdu Kanghong Pharmaceutical Group | 18.54B |
| Guangdong Zhongsheng Pharmaceutical | 18.54B |
| Walvax Biotechnology | 18.31B |
| Hybio Pharmaceutical | 18.18B |